Introduction {#s1}
============

Lissencephaly (smooth brain) is a brain malformation disorder associated with haploinsufficiency of Lissencephaly-1 (LIS1), also called PAFAH1B1 (Platelet-activating factor acetylhydrolase IB subunit alpha) ([@bib11]; [@bib25]; [@bib53]; [@bib45]). At the molecular level, LIS1 is an important regulatoratory protein controlling cytoplasmic dynein and microtubules (MTs), that is also known to have dual roles coordinating both MTs and the actin cytoskeleton ([@bib34]; [@bib35]; [@bib31]). Besides pivotal roles of LIS1 in post-mitotic neurononal migration, *Pafah1b1* mouse mutant studies suggest additional cellular functions of LIS1 in neocortical neural progenitor cell (NPC) division by regulating mitotic spindle orientation and cell fate ([@bib67]; [@bib69]; [@bib28]; [@bib4]; [@bib44]). The mitotic phenotypes of *Pafah1b1* mutants are closely related and consistent with those of other mutants of MT/dynein-associated proteins such as LGN, NDE1, and NDEL1 ([@bib5]; [@bib12]; [@bib66]). However, unlike these other mouse mutants of LIS1-interacting proteins, *Pafah1b1* mutants displayed a significant decrease in neuroepithelial stem cells in the neocortex and subsequent neonatal death compared with a less catastrophic phenotype seen in radial glial (RG) progenitors ([@bib67]). Our recent studies with human-induced pluripotent stem cells (iPSCs) of Miller-Dieker syndrome, a severe form of lissencephaly caused by heterozygosity of more than 20 genes including *PAFAH1B1*, demonstrated a prolongation of mitotic division time of oRG progenitors but not ventricular zone radial glial (vRG) progenitors ([@bib4]). All of these previous studies suggest that cellular functions of LIS1 other than MT/dynein-mediated mitotic spindle regulation dictate further mitotic progression from mitotic (M) phase to anaphase/telophase in late stages of mitosis and daughter cell separation.

Although the functions of LIS1 in F-actin regulation have been studied previously, its downstream cellular signaling pathways that regulate actomyosin during late mitosis and cytokinesis has not been explored. When cytokinesis is initiated, MTs provide positional cues for the cleavage furrow location and membrane ingression at the equatorial cortex by inducing central spindle assembly ([@bib3]; [@bib62]; [@bib64]). At this point, dynamic crosstalk between astral MTs and cortical filamentous actin (F-actin) transmit inhibitory signals at the polar cortex, which indirectly instructs cleavage furrow positioning to the equatorial cortex ([@bib6]; [@bib15]; [@bib46]). During cleavage plane formation, a small GTPase RhoA functions as a master regulator of cytokinetic furrow ingression ([@bib3]; [@bib47]) that recruits contractile ring components, including the scaffold protein Anillin ([@bib9]; [@bib22]; [@bib48]; [@bib50]) and Septin ([@bib36]; [@bib40]; [@bib48]). At the same time, Myosin II accumulates at the equatorial cortex and serves as a constriction force generator by interacting with F-actin ([@bib21]; [@bib60]; [@bib71]). However, when coordination between MTs and F-actin is perturbed, abnormally fewer or elongated astral MTs destabilize the cleavage furrow. This MT dysfunction induces actomyosin dysregulation, leading to cell membrane hyper-contractility, RhoA and F-actin mislocalization outside of the midzone/cleavage furrow, cell shape oscillation, and subsequent mitotic failure ([@bib6]; [@bib46]; [@bib52]; [@bib63]). It is important to note that LIS1 is involved in astral MT movements and F-actin polymerization, so it is possible that LIS1 contributes to important cellular processes during cytokinesis by regulating actomyosin and other cleavage furrow-associated proteins during late stages of mitosis and cytokinesis.

We hypothesized that the LIS1-dynein-MT network may be essential for cytokinesis, perhaps by fine-tuning actomyosin and cell membrane contractility. Therefore, we assessed the mitotic phenotypes of neocortical from *Pafah1b1*-deficient mouse embryos, and monitored the entire duration of mitoses of *Pafah1b1*-deficient mouse embryonic fibroblasts (MEFs), using time-lapse live-cell imaging. Through imaging of *Pafah1b1*-deficient MEFs, we found severe defects in cleavage plane positioning and dysregulation of cell membrane contractility. Here we demonstrate that LIS1 determines cleavage plane positioning through a RhoA-actomyosin signaling pathway, defining a novel molecular mechanism of LIS1 underlying spatiotemporal regulation of cell membrane contractility during mitotic cell division.

Results {#s2}
=======

Mislocalization of RhoA and Anillin in *Pafah1b1* mutant neocortical neural progenitor cells (NPCs) {#s2-1}
---------------------------------------------------------------------------------------------------

To elucidate molecular mechanisms underlying LIS1-dependent NPC regulation during neocortical development, mitotic phenotypes of *Pafah1b1*-deficient NPCs were analyzed by conducting genetic and immunohistochemical approaches on mouse neocortices derived at embryonic day 14.5 (E14.5) ([Figure 1A--E](#fig1){ref-type="fig"}). We took advantage of mosaic analysis with double markers on chromosome 11 mouse line (MADM-11; [@bib28]), since the *Pafah1b1* is located on chromosome 11 away from the centromere. To deplete *Pafah1b1* sparsely in neocortical NPCs during early embryonic development, we first generated *MADM-11^TG/TG,Pafah1b1^* (TG: tdTomato-GFP fusion) mice co-expressing the heterozygous *Pafah1b1* knock-out (KO) allele. These mice were mated with *MADM-11^GT/GT^;Emx1^Cre/+^* (GT: GFP-tdTomato fusion) to generate the experimental mosaic animals which carry sparsely labeled NPCs with different expression levels of LIS1 (*MADM-11^GT/TG,Pafah1b1^;Emx1^Cre/+^*, abbreviated as *Pafah1b1-MADM*) ([Figure 1B](#fig1){ref-type="fig"}). In this line, we identified three distinct subpopulations of labeled NPCs with different LIS doses; *Pafah1b1^+/+^* (red, labeled with tdTomato, 100% LIS1 wild-type (WT) levels), *Pafah1b1^ko/+^* (yellow, double positive for GFP and tdTomato, 50% LIS1 WT levels), and *Pafah1b1^ko/ko^* (green, labeled with GFP, 0% LIS1) NPCs in an unlabeled *Pafah1b1^ko/+^* heterozygous background. The fluorescence of each cell enabled us to distinguish the genotype of each cell. The same mating scheme was used to generate WT control animals (*MADM-11^GT/TG^;Emx1^Cre/+^*, abbreviated as WT*-MADM*) where green, red, and yellow cells are all WT expressing normal levels of 100% LIS1.

![Cleavage plane formation and positioning in the neocortical neural progenitor cells (NPCs) in WT*-MADM* and *Pafah1b1-MADM* embryos.\
(**A**) Wild-type (WT) NPCs displayed recruitment of Anillin to the basal equatorial cortex and ultimately the Anillin-ring moved to the apical surface of the ventricular zone, forming a 'U'-like shape. (**B**) Schematic representation of *Pafah1b1-MADM* mating scheme and three types of neocortical NPCs with different LIS1 expression levels. Immunoreactivity (IR) from immunohistochemistry experiment with anti-GFP and anti-tdT-c-Myc antibodies was indicated. (**C**) (e) Midbody-associated Anillin localization in WT (*Pafah1b1*^+/+^) NPCs, (f,g) Midbody-associated Anillin distribution was not detected in *Pafah1b1* heterozygous (*Pafah1b1^ko/+^*) NPCs. (h) Complete knock-out (KO) of *Pafah1b1* (*Pafah1b1^ko/ko^*) in NPCs results in mitotic arrest at the prometaphase- or metaphase-like time-points. (**D**) (i,j). WT NPCs displayed apical membrane-associated RhoA during cytokinesis. (k,l). RhoA was also co-localized with the midbody, at the future cleavage furrow. (**E**) (m,n). The cytosol from only one daughter cell retained RhoA-positive puncta in WT NPCs. (o) Complete KO of *Pafah1b1* (*Pafah1b1^ko/ko^*) resulted in detachment of NPCs away from the RhoA-positive apical membrane. Gray arrowheads: ventricular surface (apical). Scale bars: 5 μm. Quantitative data were included in [Figure 1---source data 1](#fig1sdata1){ref-type="supplementary-material"}.\
Figure 1---source data 1.Quantification of apical NPCs (RGs).](elife-51512-fig1){#fig1}

To determine whether *Pafah1b1* deficiency in neocortical NPCs results in displacement of the mitotic cleavage plane with abnormal distribution of contractile components, we assessed Anillin distribution in *Pafah1b1-MADM* neocortices compared with those of WT*-MADM* at E14.5. In the WT*-MADM* neocortex, Anillin was accumulated at the midzone during metaphase-to-anaphase ([Figure 1A--a,b](#fig1){ref-type="fig"}) and was enriched by forming a 'U' shape (basal-to-apical ingression) at the midbody of NPCs, consistent with previous observations of normal NPC cleavage in WT mice ([@bib37]; [Figure 1A--c,d](#fig1){ref-type="fig"}). In the *Pafah1b1-MADM* neocortices, the tdTomato-positive WT NPCs (red, *Pafah1b1^+/+^*) similarly displayed a normal distribution of Anillin at the apical cleavage furrow between the two daughter cells ([Figure 1C--e](#fig1){ref-type="fig"}). The tdTomato- and GFP-double-labeled *Pafah1b1* heterozygous NPCs (yellow, *Pafah1b1^ko/+^*) did not display an Anillin-rich ring associated with the midbody ([Figure 1C--f,g](#fig1){ref-type="fig"}). The *Pafah1b1-MADM* ([Figure 1B--C](#fig1){ref-type="fig"}) neocortex displayed a profound decrease in GFP-positive *Pafah1b1* homozygous KO apical NPCs located at the ventricular zone (green, *Pafah1b1^ko/ko^*). These apical *Pafah1b1^ko/ko^* NPCs were mostly found at prometaphase or metaphase and located at the ventricular surface with no obvious cell membrane-associated Anillin with dispersed patterns ([Figure 1C--h](#fig1){ref-type="fig"}), probably due to mitotic arrest after complete loss of LIS1 ([@bib67]). Abnormal distribution of Anillin in *Pafah1b1* mutant NPCs (*Pafah1b1^ko/+^*) implies that LIS1 is an important cell determinant for neocortical NPC cell cleavage and daughter cell separation during cytokinesis in a cell-intrinsic manner.

In apical NPCs of the neocortex, the highest expression of RhoA was detectable at the ventricular surface where NPC cleavage furrows were found ([@bib18]; [@bib39]). Overexpression of dominant-negative forms of RhoA in mouse NPCs in vitro induced mislocalization of cleavage furrow with diffuse and dispersed contractile ring ([@bib39]), suggesting that RhoA dictates cytokinetic progression and cleavage furrow specification. In the present study, cell membrane-bound forms of RhoA in apical NPCs were identified by fixing the embryonic brains with a 10% trichloroacetic acid (TCA) solution. In the control WT*-MADM* neocortex (*MADM-11^GT/TG^;Emx1^Cre/+^*), tdTomato illuminated the cytoplasm of dividing NPCs. At metaphase, RhoA was associated with the apical cell membrane of WT NPCs proximal to the ventricular surface ([Figure 1D--i](#fig1){ref-type="fig"}). At telophase, RhoA was enriched at the midbody located at the ventricular surface, indicating separation of the two daughter cells ([Figure 1D](#fig1){ref-type="fig"} j,k,l). However, in the *Pafah1b1-MADM* neocortex (*MADM-11^GT/TG,Lis1^;Emx1^Cre/+^*), tdTomato- and GFP-double-labeled *Pafah1b1* heterozygous NPCs (yellow, *Pafah1b1^ko/+^*) displayed an unequal distribution of RhoA skewed to the cytoplasm of only one daughter cell ([Figure 1E--m,n](#fig1){ref-type="fig"}). The GFP-positive *Pafah1b1* KO NPCs (green, *Pafah1b1^ko/ko^*) were sparsely found at the prometaphase or metaphase with apical membrane-associated RhoA ([Figure 1E--o](#fig1){ref-type="fig"}). Together, mislocalization of Anillin and RhoA in *Pafah1b1* mutant neocortical NPCs (*Pafah1b1^ko/+^*) indicates that LIS1 may contribute to cleavage plane specification and positioning during late stages of apical NPC mitosis.

Mislocalization of Anillin in apical NPCs from *Pafah1b1* heterozygous neocortex {#s2-2}
--------------------------------------------------------------------------------

We next asked whether *Pafah1b1* heterozygosity leads to changes in cytoarchitecture of the apical NPC niche at the ventricular surface of the neocortex. We deleted one copy of *Pafah1b1* in neocortical NPCs by mating *Pafah1b1* conditional knock-out (CKO) line with the *GFAP-Cre* line ([@bib72]). In control neocortex (*Pafah1b1^hc/+^* without Cre, hc: hypomorphic conditional), NPCs undergoing vertical divisions (with a vertical cleavage plane angle) possessed basally located Anillin that gradually ingressed apically with the formation of the midbody, defining final location of cleavage furrow (basal-to-apical ingression) ([Figure 2A](#fig2){ref-type="fig"}), consistent with previous findings ([@bib37]). NPCs undergoing horizontal or oblique divisions maintained a straight line of Anillin-rich immunoreactive signal in the junctional plate between two daughter cells ([Figure 2B](#fig2){ref-type="fig"}), suggesting normal cleavage furrow formation at the midzone between the two daughter cells. There were reduced numbers of NPCs undergoing vertical divisions (42%) in NPC-specific *Pafah1b1* heterozygous mutant neocortex (*GFAP-Cre; Pafah1b1^hc\ /+^*) compared with those numbers (84%) in control neocortex (*Pafah1b1^hc/+^*), consistent with our previous findings ([@bib67]). In addition, NPCs undergoing oblique and horizontal divisions in *Pafah1b1* heterozygous mutant neocortex displayed a diffuse pattern of Anillin associated with similar enrichment at both the apical and basal cell membrane. Only one apically attached daughter cell retained concentrated Anillin-positive puncta at the ventricular surface ([Figure 2B--f,g,i](#fig2){ref-type="fig"}), suggesting that *Pafah1b1* heterozygosity resulted in Anillin mislocalization during late mitosis of apical NPCs.

![Localization of Anillin-ring in neocortical NPCs from controls and *GFAP-Cre*-induced *Pafah1b1* mutant mouse embryos.\
(**A**) Normal Anillin-ring distribution during cytokinesis of *Pafah1b1* control (*Pafah1b1^hc/+^*) NPCs. hc: hypomorphic conditional allele, (a) Early anaphase, (b) Mid-anaphase with a basally located Anillin-ring, (c) 'U'-like shape Anillin-ring at the cleavage furrow, (d) Midzone-specific Anillin localization. (a,b,c) Vertical cleavage plane (60°\< α \< 90°), α: spindle angle compared to the ventricular surface, (d) Oblique and horizontal cleavage plane (0°\< α \< 60°). (**B**) Abnormal Anillin-ring localization during cytokinesis of *Pafah1b1*-deficient mutant NPCs (*GFAP-Cre; Pafah1b1^hc/+^*). (e) Basal and apical Anillin-rings at the equator of NPCs, (f,g) Moderately skewed Anillin-ring localization in only one daughter cell. (h) The equator-associated Anillin-ring was detected with tilted spindle angle in *Pafah1b1*-deficient NPCs. (i) *Pafah1b1*-deficient mutant NPCs displayed horizontal cleavage plane with apical memrbrane-associated Anillin puncta. Gray arrowheads: ventricular surface (apical). Scale bars: 5 μm. Quantitative data were included in [Figure 2---source data 1](#fig2sdata1){ref-type="supplementary-material"}.\
Figure 2---source data 1.Quantification of apical NPCs (RGs).](elife-51512-fig2){#fig2}

An imbalance in symmetric versus asymmetric NPC divisions after dose-dependent reduction of LIS1 {#s2-3}
------------------------------------------------------------------------------------------------

We hypothesized that *Pafah1b1* mutant NPCs may display an imbalance in symmetric vs. asymmetric divisions due to defects in cleavage furrow patterning and cell membrane contractility. We previously reported that neocortical NPCs in *Pafah1b1* mutants had reduced mitotic spindle angles because more cells displayed abnormal cleavage planes that were skewed to oblique and horizontal divisions ([@bib67]). Here, we analyzed neocortical NPC divisions by tracing the inheritance of atypical protein kinase C zeta (aPKC, PKCζ), an apical complex component, into each daughter cell. The cleavage furrow was identified by the location of Cadherin hole in the continuous line of N-Cadherin that indirectly indicates the contractile ring positioning ([@bib41]). The relative positioning of the mitotic spindle was defined by the midline between two chromosome sets. Thus, we determined that neocortical NPCs from *Pafah1b1*-deficient mutants (*Pafah1b1^hc/ko^*) more frequently displayed unequal inheritance of aPKCζ to the daughter cells ([Figure 3A--C](#fig3){ref-type="fig"}). In addition, apical NPCs in *Pafah1b1^hc/ko^* neocortices possessing horizontal cleavage planes displayed less polarized aPKCζ along the apical-basal axis ([Figure 3B](#fig3){ref-type="fig"}), indicating mild alterations of apical polarity in *Pafah1b1*-deficient neocortical NPCs. In *Pafah1b1^hc/+^* control neocortices, 30.7% of NPCs displayed unequal distribution of aPKCζ into the cytoplasm of the two daughter cells (presumably asymmetric divisions). However, in *Pafah1b1^hc/ko^* brains, 68.8% of NPCs displayed unequal distribution ([Figure 3C](#fig3){ref-type="fig"}). These results suggest that *Pafah1b1* deficiency in neocortical NPCs results in abnormal cleavage furrow positioning that may induce unequal inheritance and distribution of cell fate determinants into two daughter cells that ultimately leads to an increase in asymmetric (presumably neurogenic) NPC divisions.

![Alterations in symmetric and asymmetric divisions determined by equal vs. unequal inheritance of atypical PKC (aPKC, PKCζ) and Cadherin holes.\
(**A**) Normal cytokinesis in neocortical NPCs from *Pafah1b1* controls (*Pafah1b1^hc/+^*). Upper panel: Control NPCs displayed vertical cleavage with equal inheritance of aPKC and Cadherin hole. Lower panel: Control NPCs displayed vertical cleavage with unequal inheritance of aPKC and Cadherin hole -- presumably reflecting an asymmetric neurogenic division. (**B**) Upper panel: *Pafah1b1*-deficient NPCs (*Pafah1b1^hc/ko^*) displayed vertical cleavage with unequal inheritance of aPKC and Cadherin hole. Lower panel: *Pafah1b1*-deficient NPCs displayed horizontal cleavage with unequal and very skewed inheritance of aPKC and Cadherin hole. This *Pafah1b1*-deficient NPC retained less polarized aPKC/N-Cadherin protein distribution (less apical enrichment of aPKC and N-Cadherin) along the apical-basal axis. (**C**) Disturbances in the frequencies of equal vs. unequal inheritance of cell fate determinants in *Pafah1b1*-deficient NPCs. Gray arrowheads: ventricular surface (apical). Scale bars: 5 μm. Quantitative data were included in [Figure 3---source data 1](#fig3sdata1){ref-type="supplementary-material"}.\
Figure 3---source data 1.Quantification of aPKCζ inheritance in apical NPCs (RGs).](elife-51512-fig3){#fig3}

Perturbed daughter cell separation and an increase in binucleation during mitosis of *Pafah1b1* mutant MEF {#s2-4}
----------------------------------------------------------------------------------------------------------

We also tested whether *Pafah1b1* deficiency impairs cleavage plane positioning and completion of mitosis in MEFs using time-lapse microscopy. We visualized mitotic events of late stages of mitosis of MEFs in vitro in greater detail than we could do in the neocortex in vivo. We examined the frequency of normal daughter cell separation with complete abcission from both WT MEFs (*Pafah1b1^+/+^*) and mutant *Pafah1b1* compound heterozygous MEFs (*Pafah1b1^hc/ko^*) expressing 35% of LIS1 compared to normal WT levels ([@bib67]). Sequential mitotic events were monitored by time-lapse live-cell imaging using mCherry-α-Tubulin, a fluorescently labeled MT marker, and histone 2B (H2B)-GFP, a chromosomal probe ([@bib44]). A majority of WT MEFs displayed successful daughter cell separation (85.4 ± 6.1%), while in *Pafah1b1^hc/ko^* MEFs, this frequency was decreased (18.7 ± 8%) ([Figure 4A](#fig4){ref-type="fig"}). By contrast, binucleated daughter cells were increased in *Pafah1b1^hc/ko^* MEFs (40.1 ± 1.2%) relative to WT MEFs (5.1 ± 3.1%) ([Figure 4B](#fig4){ref-type="fig"}). To assess whether an increase in incomplete cell separation leads to changes in apoptotic cell death, we immunostained cleaved caspase-3. *Pafah1b1^hc/ko^* MEFs had an increased number of cleaved caspase-3-immunoreactive cells compared with WT, suggesting that *Pafah1b1* deficiency induces more frequent apoptosis of MEFs ([Figure 4C](#fig4){ref-type="fig"}). We also confirmed an increase in cell death (from 3- to 6-fold) from live-cell imaging of *Pafah1b1^hc/ko^* MEFs.

![Loss of *Pafah1b1* in mouse embryonic fibroblasts (MEFs) impairs normal cytokinesis and leads to binucleation of the daughter cells.\
(**A**) *Pafah1b1* mutant mouse embryonic fibroblasts (MEFs) (*Pafah1b1^hc/ko^*) displayed failure of cytokinesis, daughter cell separation, compared with WT MEFs, analyzed by time-lapse live-cell imaging. (**B**) Increased binucleation by fused daughter cells from MEFs with acutely deleted *Pafah1b1* (*CAGG-CreERT2; Pafah1b1^hc/hc^*). (**C**) Increased apoptotic cell death from *Pafah1b1^hc/ko^* MEFs compared with WT MEFs (green: cleaved caspase-3, red: α-Tubulin, blue: DAPI). (**D**) Acutely induced *Pafah1b1* conditional knock-out (CKO) mutant MEFs (*CAGG-CreERT2; Pafah1b1^hc/hc^* + TM^12h^) also displayed less frequency of normal daughter cell separation compared with control MEFs (*CAGG-CreERT2; Pafah1b1^+/+^* + TM^12h^). (**E**) An increased trend in binucleation was found in *Pafah1b1* CKO mutant MEFs relative to control MEFs. However, it did not reach significant. Scale bars: 50 μm. Quantitative data were included in [Figure 4---source data 1](#fig4sdata1){ref-type="supplementary-material"}.\
Figure 4---source data 1.Quantification of MEFs.](elife-51512-fig4){#fig4}

To determine whether acute loss of *Pafah1b1* also induces defective cell separation, we derived MEFs containing CKO alleles of *Pafah1b1* and tamoxifen (TM)-inducible *CAGG-CreERT2* line ([@bib26]) with the genotype *CAGG-CreERT2; Pafah1b1^hc/hc^*. We treated these MEFs with 4-hydroxy-TM for 12 hr and compared mitotic phenotypes with control MEFs (*CAGG-CreERT2; Pafah1b1^+/+^*). Similar to *Pafah1b1^hc/ko^* mutant MEFs, acute deletion of *Pafah1b1* in TM-treated *Pafah1b1* CKO MEFs (*CAGG-CreERT2; Pafah1b1^hc/hc^* +TM^12\ h^) induced a decrease in normal daughter cell separation (36.6 ± 5.3%) compared with control levels (69.4 ± 4.3%) ([Figure 4D](#fig4){ref-type="fig"}). Consistently, a trend of frequent daughter cell separation failure and higher percentage of binucleation (25.8 ± 6.4%) than controls (*CAGG-CreERT2; Pafah1b1^+/+^* +TM^12\ h^) (15.7 ± 6.1%) was observed from live-cell imaging ([Figure 4E](#fig4){ref-type="fig"}) but this was not statistically significant.

Cell shape oscillation and mitotic spindle rocking during mitosis of *Pafah1b1* mutant MEFs {#s2-5}
-------------------------------------------------------------------------------------------

We analyzed movements of MT-enriched midbody and cleavage plane positioning throughout the entire mitotic cell cycle by live-cell imaging. Acute deletion of *Pafah1b1* in MEFs (*CAGG-CreERT2; Pafah1b1^hc/hc^* +TM^12\ h^) resulted in drastic cell shape oscillation ([Figure 5A](#fig5){ref-type="fig"}, [Video 1](#video1){ref-type="video"}), similar to the phenotypes described in Anillin-depleted cells ([@bib13]; [@bib33]; [@bib50]; [@bib60]; [@bib70]). At the anaphase onset of *Pafah1b1* mutant MEFs, the midbody was properly positioned in the central spindle zone. However, the position of the midbody was gradually destabilized and began vigorously oscillating between the two daughter cells. Surprisingly, the initially separated chromosome sets moved back and forth between two daughter cells and mitotic spindle rocking was prominent throughout this process. This phenotype was previously termed 'hyper-contractility' in cells with depleted contractile ring components, and is caused by hyper-activity of the actomyosin during cytokinesis ([@bib65]). Surprisingly, in one example seen in *Pafah1b1* mutant MEFs ([Figure 5B](#fig5){ref-type="fig"}, [Video 2](#video2){ref-type="video"}), one daughter cell inherited two-sets of chromosomes with binucleation while the other daughter cell underwent cell death processes.

![Loss of *Pafah1b1* results in vigorous cell shape oscillation and mitotic spindle rocking that ultimately leads to cytokinetic failure with aberrant cleavage plane positioning.\
(**A**) Acutely deleted *Pafah1b1* mutant MEFs (*CAGG-CreERT2; Pafah1b1^hc/hc^* + TM^12h^) displayed severe cleavage plane defects during cytokinesis. There was instability of the midbody (highly concentrated with red fluorescence: mCherry-α-Tubulin) accompanied by cell shape oscillation and spindle rocking (green: H2B-GFP). Scale bar: 20 μm. (**B**) The MEFs with acutely deleted *Pafah1b1* displayed abnormal cell shape and chromosome oscillation between two daughter cells. Yellow arrow (28'): anucleated one daughter cell, White arrow (36'): binucleated and bi-lobed daughter cell. Scale bar: 10 μm. (**C**) An increase in the frequency of hyper-contractility phenotype in *Pafah1b1^hc/ko^* MEFs. (**D**) Single snapshots from the merged images with DIC (differential interference contrast) and fluorescence images (green: H2B-GFP, red: mCherry-α-Tubulin, gray: DIC) from time-lapse movies (black arrows: aberrant formation of huge polar blebs). (**E**) Hyper-contractility quantification indicates that *Pafah1b1* CKO mutant MEFs have increases in cell membrane blebbing phenotypes than control MEFs. Scale bars: 10 μm. Quantitative data were included in [Figure 5---source data 1](#fig5sdata1){ref-type="supplementary-material"}.\
Figure 5---source data 1.Quantification of MEFs.](elife-51512-fig5){#fig5}

###### Cytokinesis defects in *Pafah1b1* mutant MEFs.

Time-lapse live cell imaging of mitotic cell division from *Pafah1b1* mutant MEFs (*CAGG-CreERT2; Pafah1b1^hc/hc^* +TM^12\ h^) treated with 4-hydroxy tamoxifen (TM). H2B-GFP and mCherry-α-Tubulin labeled fluorescence signals were acquired with a 1 min interval by Nikon Ti epifluorescence microscope. During cytokinesis of *Pafah1b1*-deficient MEFs, severe cytokinesis defects were observed such as vigorous cell shape oscillation and spindle rocking.

###### Formation of binucleated daughter cells by cytokinesis failure in *Pafah1b1* mutant MEFs.

Time-lapse live cell imaging of mitotic cell division from *Lis1* mutant MEFs (*CAGG-CreERT2; Pafah1b1^hc/hc^* +TM^12\ h^) treated with 4-hydroxy TM. H2B-GFP and mCherry-α-Tubulin labeled fluorescence signals were acquired with a 30 s interval by Nikon Ti epifluorescence microscope. The *Pafah1b1*-deficient MEFs underwent abnormal cytokinesis and resulted in formation of binucleated daughter cells.

We next examined the incidence of the hyper-contractility phenotypes during MEF mitosis. WT MEFs rarely displayed oscillated cell membrane movements (3.6 ± 3.6%). By contrast, more than half of the mitosis (56.2 ± 8.4%) in *Pafah1b1^hc/ko^* MEFs exhibited the hyper-contractility phenotypes ([Figure 5C](#fig5){ref-type="fig"}). The incidence of ectopic membrane bulges was increased in *Pafah1b1* mutant MEFs which prompted us to monitor cell shape changes and cell membrane dynamics by merging phase-contrast images in live-cell imaging analysis. We found that *Pafah1b1^hc/ko^* MEFs frequently showed cell membrane blebbing ([Figure 5D](#fig5){ref-type="fig"}) and the size of ectopic membrane blebs was much larger than those in WT MEFs. In accordance with these findings, the hyper-contractility phenotypes with cell membrane blebbing were more frequent in *Pafah1b1* CKO MEFs (*CAGG-CreERT2; Pafah1b1^hc/hc^* +TM^12\ h^) (40.5 ± 8.4%) compared with control MEFs (*CAGG-CreERT2; Pafah1b1^+/+^* +TM^12\ h^) (13.5 ± 2.4%) ([Figure 5E](#fig5){ref-type="fig"}).

Mislocalization of RhoA and contractile ring components in mitosis of *Pafah1b1* mutant MEFs {#s2-6}
--------------------------------------------------------------------------------------------

We tested whether critical regulators of cytokinesis contribute to *Pafah1b1*-deficiency-induced cell membrane hyper-contractility. Since RhoA is an important master GTPase regulating cytokinesis, we examined RhoA localization in *Pafah1b1* mutant MEFs fixed with 10% TCA ([@bib68]). In WT MEFs, the active forms of RhoA symmetrically accumulated at both sides of the equatorial cortex and were concentrated in the midbody at late telophase and during cytokinesis ([Figure 6A](#fig6){ref-type="fig"}). From anaphase to telophase, RhoA colocalized with the cell membrane-associated Anillin, a key component of the contractile ring that defines the cleavage furrow ingression site. By contrast, 60% of *Pafah1b1^hc/ko^* MEFs displayed mislocalization of the cleavage furrow with the formation of large polar blebs in ectopic membrane sites ([Figure 6B](#fig6){ref-type="fig"}). An aberrant cleavage furrow was found at only one side of the cell equatorial cortex of *Pafah1b1^hc/ko^* MEFs, resulting in asymmetric mislocalization of RhoA and Anillin ([Figure 6B](#fig6){ref-type="fig"}, upper panel). The binucleated *Pafah1b1^hc/ko^* MEFs displayed protruding polar blebs in ectopic locations ([Figure 6B](#fig6){ref-type="fig"}, lower panel). Intriguingly, RhoA immunoreactive signal decorated the cell membrane of all of these polar blebs, suggesting that RhoA and actomyosin may be the primary signals to produce aberrant membrane bulges in *Pafah1b1^hc/ko^* MEFs.

![*Pafah1b1* mutant MEFs display mislocalization of RhoA and Anillin, an important contractile ring component.\
(**A**) WT MEFs displayed normal cleavage furrow positioning labeled with TCA-fixed RhoA and Anillin co-staining at the equatorial cortex from early anaphase to telophase. (**B**) *Pafah1b1^hc/ko^* MEFs displayed mislocalization of RhoA and Anillin. Upper panel: asymmetric cleavage furrow formation. Lower panel: binucleated cells with RhoA-positive aberrant membrane blebs (**A,B**) (green: RhoA, red: Anillin, blue: DAPI). (**C**) WT MEFs displayed an Anillin-positive zone in the cell equator. The polar-cortex-associated cortical P150glued dynactin staining pattern was excluded from and did not overlap with the Anillin-ring. (**D**) *Pafah1b1^hc/ko^* MEFs exhibited reduced cortical P150glued dynactin at the polar cortex and also have decreased and dispersed Anillin distribution to the equatorial cortex. (**C,D**) (green: P150glued dynactin, red: Anillin, blue: DAPI). (**E**) Quantification of normal, asymmetric, dispersed, and central MR-associated Anillin distribution in MEFs. Scale bars: 10 μm. Quantitative data were included in [Figure 6---source data 1](#fig6sdata1){ref-type="supplementary-material"}.\
Figure 6---source data 1.Quantification of MEFs.](elife-51512-fig6){#fig6}

Since the LIS1-dynein-dynactin complex is associated with the cortical cell membrane ([@bib14]; [@bib44]), it is plausible that cortical dynactin, P150^glued^, may be less enriched in the cell membrane and cause Anillin mislocalization in *Pafah1b1^hc/ko^* MEFs. Cortical P150^glued^ was incorporated within the polar cortex but it was excluded in the cleavage furrow where Anillin was associated with the equatorial cortex in WT MEFs ([Figure 6C](#fig6){ref-type="fig"}). However, reciprocal exclusion of polar P150^glued^ vs. equatorial Anillin was less obvious in *Pafah1b1^hc/ko^* MEFs ([Figure 6D](#fig6){ref-type="fig"}; [@bib44]). From anaphase to telophase, the cells with cleavage furrow-associated Anillin were reduced in *Pafah1b1^hc/ko^* MEFs (27.1%) relative to WT control *Pafah1b1^+/+^* MEFs (72.3%) ([Figure 6E](#fig6){ref-type="fig"}, in gray).

We found that *Pafah1b1*-deficient MEFs had mislocalization of a key contractile ring component, Anillin. Hence, we examined cellular localization of LIS1 and Anillin during late stages of mitosis and cytokinesis and evaluated co-localization between LIS1 and Anillin. However, only rabbit-derived antibodies against LIS and Anillin were sufficiently specific in MEFs, so we were not able to perform direct dual immunocytochemistry with combination of LIS1 and Anillin antibodies. When we alternatively traced LIS1 and Anillin antibody separately with α-Tubulin, we found no evidence of substantial overlap of intercellular compartments with LIS1-Anillin in MEFs undergoing late mitosis and cytokinesis. During mitotic division of WT MEFs, LIS1 was localized only to the centrosomes in metaphase-to-anaphase and the central MTs during cytokinesis displaying mostly cytosolic distribution ([Figure 7A](#fig7){ref-type="fig"}), while Anillin was initially seen on the lateral cortex and later specifically accumulated in the cytokinetic abcission ring between two central MT bundles, near the equatorial cortex ([Figure 7B](#fig7){ref-type="fig"}). These results support that LIS1 may only indirectly regulate Anillin through F-actin cytoskeleton regulation.

![Cellular localization of LIS1 and Anillin in MEFs during cytokinesis.\
(**A**) Wild-type (WT) MEFs were analyzed for immunocytochemistry with Rabbit anti-LIS1 and Rat anti-α-Tubulin. (**B**) With Rabbit anti-Anillin and Rat anti-α-Tubulin. Scale bars = 10 μm.](elife-51512-fig7){#fig7}

Mislocalization of F-actin and myosin II in mitosis of *Pafah1b1* mutant MEFs {#s2-7}
-----------------------------------------------------------------------------

A previous study demonstrated that the leading process-associated F-actin is misregulated during migration of post-mitotic neurons in *Pafah1b1^ko/+^* mutants ([@bib34]). Actin dysfunction induced by loss of LIS1 may lead to cytokinetic defects and hyper-contractility seen in *Pafah1b1^hc/ko^* MEFs. To test this possibility, we co-immunostained MEFs with phalloidin (F-actin zone) and dynein intermediate chain (DIC 74.1). WT MEFs had an F-actin zone located at the midbody that also colocalized with DIC ([Figure 7A](#fig7){ref-type="fig"}, upper panel). By contrast, *Pafah1b1^hc/ko^* MEFs had wider F-actin cortical patches at the midzone that extended to the polar cortex in one daughter cell compared with WT MEFs. Central MT-associated F-actin fibers were also evident in *Pafah1b1^hc/ko^* MEFs ([Figure 7A](#fig7){ref-type="fig"}, lower panel).

We next examined the localization of Myosin II in *Pafah1b1^hc/ko^* MEFs relative to WT MEFs. Myosin II is the main molecular motor of the cortical contraction complex of cytokinesis, cooperatively working with the F-actin ([@bib49]). In WT MEFs, non-muscle myosin heavy chain II A (NMHCIIA) immunoreactive signal at the spindle midzone overlapped with the F-actin focus zone ([Figure 8B](#fig8){ref-type="fig"}, upper panel). By contrast, we found that MHCIIA distribution was diffused and dispersed at the spindle midzone in *Pafah1b1^hc/ko^* MEFs ([Figure 8B](#fig8){ref-type="fig"}, lower panel). Quantitation of dispersed MHCIIA and F-actin distribution indicated that *Pafah1b1^hc/ko^* MEFs had fewer cells with normal cleavage furrow-associated actomyosin patterns (*Pafah1b1^+/+^*, 73.4% vs*. Pafah1b1^hc/ko^*, 29.7% - in gray). Conversely, *Pafah1b1^hc/ko^* MEFs showed an increase in cells with ectopic distribution of actomyosin (*Pafah1b1^+/+^*, 26.6% vs. *Pafah1b1^hc/ko^*, 70.3% - in red) ([Figure 8C](#fig8){ref-type="fig"}). These findings suggest that cortical constriction at the equatorial cortex was impaired in *Pafah1b1^hc/ko^* MEFs, leading to mispositioning of the cleavage furrow by actomyosin dysfunction.

![*Pafah1b1* mutant MEFs show alterations in F-actin focus zone and Myosin II motor localization during the late stages of mitosis.\
(**A**) WT MEFs with accumulation of non-muscle myosin heavy chain II-A (NMHCIIA) at the cell equator. Colocalization of staining of NMHCIIA and F-actin (phalloidin)-focusing zone (green: NMHCIIA, red: F-actin, blue: DAPI). (**B**) *Pafah1b1^hc/ko^* MEFs displayed dispersed and less-focused actomyosin at the cell equator. (green: NMHCIIA, red: F-actin, blue: DAPI). (**C**) Quantification of normal and dispersed NMHCIIA and F-actin distribution in MEFs. Scale bars: 10 μm. Quantitative data were included in [Figure 8---source data 1](#fig8sdata1){ref-type="supplementary-material"}.\
Figure 8---source data 1.Quantification of MEFs.](elife-51512-fig8){#fig8}

Abnormal Myosin II movements during mitosis of *Pafah1b1* mutant MEFs {#s2-8}
---------------------------------------------------------------------

We also monitored actomyosin dynamics by performing time-lapse live-cell imaging of non-muscle myosin regulatory light chain1 (MRLC1)-GFP in MEFs. MRLC1-GFP is a reliable molecular probe to illustrate the localization of the Myosin II ([@bib2]; [@bib42]). We infected MEFs with MRLC1-GFP and H2B-tdTomato retroviruses to visualize Myosin II and chromosomes, respectively. In control MEFs (*CAGG-CreERT2; Pafah1b1^+/+^* +TM^24\ h^), MRLC1 accumulated at the equatorial cortex and the contractile ring, then it constricted normally ([Figure 9A](#fig9){ref-type="fig"}, [Video 3](#video3){ref-type="video"}). By contrast, Cre-inducible *Pafah1b1* CKO mutant MEFs (*CAGG-CreERT2; Pafah1b1^hc/hc^* +TM^24\ h^) displayed impairments in Myosin II movements ([Figure 9B](#fig9){ref-type="fig"}, [Video 4](#video4){ref-type="video"}). Cleavage furrow ingression first occurred but regressed abnormally, with failure to restrict the cleavage furrow at the equatorial cortex. Cleavage furrow mispositioning occurred and resulted in chromosome missegregation. Multiple ectopic membrane bulges were found near the polar cortex in *Pafah1b1* mutant MEFs, suggesting that aberrant cytoplasmic pushing forces may be generated by ectopically located Myosin II.

![Myosin-II is abnormally distributed in *Pafah1b1* mutant MEFs during late stages of mitosis.\
(**A**) WT MEFs displayed normal recruitment of the myosin regulatory light chain 1 (MRLC, green) of Myosin-II subunit at the equatorial cortex during cytokinesis. Dark black spots inside of the cells indicate chromosome sets. (**B**) *Pafah1b1* mutant MEFs (*CAGG-CreERT2; Pafah1b1^hc/hc^* + TM^24h^) infected with MRLC1-GFP (green) and H2B-tdTomato (magenta), displayed cytokinesis failure with an asymmetrically mispositioned cleavage furrow. (**C**) *Pafah1b1* mutant MEFs clearly displayed uncoupling between chromosome separation (usually before cytokinesis onset) and cleavage furrow ingression. *Pafah1b1* mutant MEFs (4') still maintained unsegregated tetraploid chromosomes to initiate furrow contraction from the actomyosin ring. (Yellow arrowheads: initial accumulation of MRLC1, White arrows: final cleavage furrow positioning). Scale bars: 5 μm.](elife-51512-fig9){#fig9}

###### Myosin II localization during cytokinesis of wild-type (WT) MEFs.

Time-lapse live cell imaging of mitotic cell division from wild-type (WT) MEFs. Myosin regulatory light chain 1 (MRLC1)-GFP and H2B-tdTomato labeled fluorescence signals were acquired with a 30 s interval by Nikon Ti spinning disk confocal microscope. In normal cytokinesis, MRLC1 was recruited to the equatorial cortex and formed the cleavage furrow.

###### Abnormal Myosin II movements during cytokinesis of *Pafah1b1* mutant MEFs.

Time-lapse live cell imaging of mitotic cell division from *Pafah1b1* mutant MEFs (*CAGG-CreERT2;Pafah1b1^hc/hc^* +TM^24\ h^). Myosin regulatory light chain 1 (MRLC1)-GFP and H2B-tdTomato labeled fluorescence signals were acquired with a 30 s interval by Nikon Ti spinning disk confocal microscope. In *Pafah1b1* mutant MEFs, MRLC1 was first recruited to the equatorial cortex. However, we found failure to properly restrict the cleavage furrow at the equatorial cortex.

In the severely affected cells, *Pafah1b1* mutant MEFs displayed an uncoupling between chromosome segregation and cytokinesis ([Figure 9C](#fig9){ref-type="fig"}, [Video 5](#video5){ref-type="video"}). In normal cytokinesis, chromosome sets first separated into the two daughters, followed by equatorial constriction to initiate cytokinesis. However, this sequential progression of cytokinesis was disrupted in *Pafah1b1* mutant MEFs. Although chromosome sets did not segregate precisely into two daughter cells before the anaphase onset of mitotic spindle elongation, actomyosin-mediated hyper-contractility of the cell membrane triggered cytokinesis progression, producing binucleated cells.

###### Uncoupling between chromosome segregation and cytokinesis in *Pafah1b1* mutant MEFs.

Time-lapse live cell imaging of mitotic cell division from *Pafah1b1* mutant MEFs (*CAGG-CreERT2; Pafah1b1^hc/hc^* +TM^24\ h^). Myosin regulatory light chain 1 (MRLC1)-GFP and H2B-tdTomato labeled fluorescence signals were acquired with a 30 s interval by Nikon Ti spinning disk confocal microscope. We observed frequent uncoupling between chromosome segregation and cytokinesis in *Pafah1b1* mutant MEFs.

Failure to maintain contractile ring components at the equatorial cortex in *Pafah1b1* mutant MEFs {#s2-9}
--------------------------------------------------------------------------------------------------

To test whether the actomyosin dysfunction in *Pafah1b1* mutant MEFs exert deleterious effects on the recruitment of contractile components to the equatorial cortex, we performed time-lapse live-cell imaging of Septin6 (SEPT6)-GFP ([@bib20]). Like Anillin, the Septin complex is the key component of the contractile ring during cell cleavage. In control MEFs, SEPT6 was enriched at the equatorial cortex and stayed at the cleavage furrow ingression site ([Figure 10A](#fig10){ref-type="fig"}, [Video 6](#video6){ref-type="video"}). However, after acute *Pafah1b1* deletion in *Pafah1b1* CKO mutant MEFs (*CAGG-CreERT2; Pafah1b1^hc/hc^* +TM^24\ h^), SEPT6 was initially observed at the equatorial cortex but then it regressed, and weak SEPT6 accumulation was detected at the cell equator accompanied by cortical deformation and chromosome oscillation/rocking (chromosomes were identified as darker spots in the SEPT6-GFP background) ([Figure 10B](#fig10){ref-type="fig"}, [Video 7](#video7){ref-type="video"}). Further live-cell imaging of SEPT6-GFP infected MEFs showed that the frequency of cytokinetic failure with concomitant SEPT6 mislocalization was increased by 4.7-fold in *Pafah1b1* mutant MEFs (66.7% in *Pafah1b1^hc/ko^*) compared with WT controls (14.3% in *Pafah1b1^+/+^*) ([Figure 10C](#fig10){ref-type="fig"}). Intercellular cytokinetic bridges and binucleation events resulted from incomplete cytokinesis were observed only from *Pafah1b1*-deficient mutant MEF, not like WT MEFs. Together, these results indicate that the contractile ring components were not strictly retained at the equatorial cortex, similar to the defective localization of actomyosin, resulting in hyper-contractility and cytokinesis failure in *Pafah1b1* mutant MEFs.

![The contractile ring component SEPT6 is not properly maintained at the equatorial cortex in *Pafah1b1* mutant MEFs.\
(**A**) WT MEFs displayed normal recruitment of Septin 6 (SEPT6-GFP, in green), an actomyosin-fiber crosslinking protein composed of contractile ring, to the equatorial cortex. (**B**) *Pafah1b1* mutant MEFs (*CAGG-CreERT2; Pafah1b1^hc/hc^* + TM^24h^) displayed cell shape oscillation with spindle/chromosome rocking. *Pafah1b1* mutant MEFs displayed chromosome missegregation and failure to maintain proper contractile ring contraction sites. Dark black spots inside of the cells indicate the chromosome sets. (Yellow arrowheads: initial accumulation of SEPT6, White arrows: final cleavage furrow positioning). (**C**) Quantification of cytokinetic failure with abnormal SEPT6-GFP distribution indicates that binucleation events and incomplete cytokinesis occur more frequently in *Pafah1b1*-deficient mutant MEFs than WT control MEFs. Scale bars: 10 μm. Quantitative data was included in [Figure 10---source data 1](#fig10sdata1){ref-type="supplementary-material"}.\
Figure 10---source data 1.Quantification of MEFs.](elife-51512-fig10){#fig10}

###### Septin localization during cytokinesis of wild-type (WT) MEFs.

Time-lapse live cell imaging of mitotic cell division from wild-type (WT) MEFs. Septin 6 (SEPT6)-GFP labeled fluorescence signals were acquired with a 30 s interval by Nikon Ti spinning disk confocal microscope. In normal cytokinesis, Septin-associated contractile ring complex was recruited to the equatorial cortex and formed the cleavage furrow.

###### Abnormal Septin localization during cytokinesis of *Pafah1b1* mutant MEFs.

Time-lapse live cell imaging of mitotic cell division from *Lis1* mutant MEFs (*CAGG-CreERT2; Pafah1b1^hc/hc^* +TM^24\ h^). Septin 6 (SEPT6)-GFP labeled fluorescence signals were acquired with a 30 s interval by Nikon Ti spinning disk confocal microscope. We observed SEPT signals at the equatorial cortex initially but then it regressed with vigorous cortical deformation and chromosome oscillation/rocking.

Modulation of RhoA hyper-activity in WT and *Pafah1b1* mutant MEFs {#s2-10}
------------------------------------------------------------------

If RhoA was hyper-activated in *Pafah1b1* mutant MEFs, the cells expressing a constitutively active form of RhoA (CA-RhoA) might mimic cytokinesis defects found in the *Pafah1b1* mutant MEFs. To test this possibility, WT MEFs were infected with retrovirus encoding human CA-RhoA (CA-RhoA)-GFP fusion protein. As expected, CA-RhoA-GFP-infected WT MEFs (*Pafah1b1^+/+^* + CA-RhoA-GFP) displayed an increased frequency of cytokinesis failure with mislocalization of Anillin, similar to *Pafah1b1^hc/ko^* MEFs ([Figure 11A](#fig11){ref-type="fig"}). WT MEFs infected with GFP control retrovirus (*Pafah1b1^+/+^* + GFP) displayed normal cytokinesis ([Figure 11B](#fig11){ref-type="fig"}).

![Overexpression of a constitutively active form of RhoA recapitulates cytokinetic failure similar to those are seen *Pafah1b1* mutant MEF and a dominant negative form or RhoA rescues hyper-activity of RhoA observed in *Pafah1b1* mutant MEFs.\
(**A**) WT MEFs expressing a constitutively active form of RhoA (CA-RhoA) displayed abnormal Anillin distribution during cytokinesis consistent with cytokinesis defects seen in *Pafah1b1^hc/ko^* MEFs. (**B**) The *Pafah1b1^hc/ko^* MEFs expressing a dominant negative form of RhoA (DN-RhoA) displayed partially rescued cytokinesis phenotypes similar to WT control MEFs. Scale bars: 10 μm. Quantitative data were included in [Figure 11---source data 1](#fig11sdata1){ref-type="supplementary-material"}.\
Figure 11---source data 1.Quantification of MEFs.](elife-51512-fig11){#fig11}

Since *Pafah1b1^hc/ko^* MEFs displayed the mitotic phenotypes resembling RhoA hyper-activity, we hypothesized that inhibition of RhoA by overexpression of a dominant negative form of RhoA (DN-RhoA) may ameliorate cytokinesis defects in *Pafah1b1^hc/ko^* MEFs. *Pafah1b1^hc/ko^* MEFs infected with retrovirus encoding a human DN-RhoA (DN-RhoA)-GFP fusion protein (*Pafah1b1^hc/ko^* + DN-RhoA-GFP) displayed a decreased frequency of cytokinesis defects compared with control MEFs (*Pafah1b1^hc/ko^* + GFP) ([Figure 11B](#fig11){ref-type="fig"}). These results imply that *Pafah1b1^hc/ko^* MEFs displayed hyper-activation of RhoA and inhibition of RhoA that enabled the rescue of cytokinesis defects seen in *Pafah1b1^hc/ko^* MEFs.

Discussion {#s3}
==========

A number of previous studies have demonstrated that LIS1 is required for neuronal migration and the production of the appropriate numbers of post-mitotic neurons that migrate into their functional cortical layers during embryonic brain development ([@bib17]; [@bib29]; [@bib57]; [@bib61]; [@bib69]; [@bib28]). In addition, LIS1 plays an important role in mitotic spindle orientation by controlling MTs and dynein complex in the interphase and metaphase of MEFs and neocortical NPCs ([@bib14]; [@bib67]; [@bib44]). However, during late stages of mitosis including cytokinesis, the cellular functions of LIS1 have not been clearly elucidated. Here we provide new evidence that LIS1 plays a crucial role in regulating cleavage plane positioning at late stages of mitosis and cytokinesis during early mouse development. We demonstrated the instructive functions of LIS1 in spindle orientation segregating the cell fate determinants into two daughter cells during mitosis, and LIS1 also regulates RhoA and Anillin-ring localization during cytokinesis. Collectively, this study provides key insights into underlying cellular mechanisms of which *Pafah1b1* deficiency leads to impairments in neurogenesis as well as defects in neuronal migration.

Since *Pafah1b1^hc/ko^* NPCs display severe mitotic progression perturbation causing cell cycle arrest at prometaphase and metaphase and frequent apoptosis in the neocortex ([@bib17]; [@bib67]), we needed to employ genetically manipulated MADM mouse lines to identify the sparsely labeled apical NPCs and daughter cells in *Pafah1b1* mutant embryonic brains in vivo. *Pafah1b1^hc/ko^* NPCs also exhibited severe mitotic defects and it was not possible to culture viable NPCs in vitro. Thus, it was unclear that *Pafah1b1* deficiency in NPCs leads to the same or similar cytokinetic phenotypes seen in MEFs in vitro. In the developing mouse brains, neocortical NPCs express specific nuclear transcription factors (such as PAX6, SOX2) to maintain its proliferative capacity and potency to promote neurogenesis. Neocortical NPCs undergo complex basal-to-apical abcission-mediated cytokinetic process in vivo and they also generate one daughter cell with a different fate, a neuron with different lineage depending on the birth date and subtypes of NPCs in regionally specified neocortical domain. By contrast, MEFs only generate two MEFs with symmetric divisions. Despite the different tissue origins of these two distinct cell types (MEFs and NPCs), both MEF and NPC populations share cellular and cytoarchitectural features during cytokinesis. We confirmed that NPCs retain apical RhoA and Anillin localization when they undergo cytokinesis at the ventricular surface where F-actin polarization occurred in vivo. RhoA and Anillin play crucial roles in determining cytokinetic furrow localization by cross-interacting with F-actin and Myosin II at the equatorial cell membrane and the midbody. It appears that RhoA and Anillin-mediated cytokinetic furrow formation is controlled in a similar manner in both MEFs in vitro and apical NPCs in vivo (vRGs). Multiple in vitro studies have highlighted that genetic mutant MEFs are versatile and reliable cell types to investigate cellular mechanisms underlying cytokinetic defects, including those in the developing brain ([@bib30]; [@bib54]; [@bib8]; [@bib58]). In genetically targeted MEFs with reduced protein dose (e.g. Kif20b, Plk4, Ect2, and P27), cytokinesis-associated phenotypes were found, including multi-nucleation and centrosome amplification. Therefore, the use of MEFs enabled us to perform long-term live-cell imaging for various analyses that were not possible in NPCs in vitro or in mouse brains in vivo.

These *Pafah1b1* mutant MEF studies of late mitosis and cytokinesis using live-cell imaging revealed that LIS1 restricts the cleavage furrow location at the equatorial cortex by inhibiting cell membrane hyper-contractility, demonstrating that LIS1 plays a critical role in cleavage plane specification as well as in actomyosin-mediated cell membrane contractility. We discovered that *Pafah1b1* mutant MEFs displayed abnormal cellular phenotypes at late stages of mitosis and cytokinesis, with increased incidence of binucleation and cell death resulted from the failure in cell separation. Cell shape oscillations and chromosome rocking along the mitotic spindles were also evident in *Pafah1b1* mutant MEFs, surprisingly similar to those of Anillin-depleted cells ([@bib13]; [@bib33]; [@bib50]; [@bib60]; [@bib70]). Together, these results suggest that *Pafah1b1* deficiency in MEFs induces cleavage furrow mispositioning and failure in the recruitment of contractile ring components to the equatorial cortex. Intriguingly, cell shape oscillation and cytokinesis defects were also previously reported in nocodazole-treated cells ([@bib6]), suggesting that misregulation of either MT or the MT-actomyosin interface at the cell membrane may induce hyper-contractility leading to abnormal membrane contraction in *Pafah1b1* mutant MEFs. During cytokinesis, *Pafah1b1*-dependent cell membrane contractility may be mediated indirectly by the dyregulation of astral MTs reaching to the cell membrane ([@bib44]).

We aimed to identify the molecular mechanisms underlying *Pafah1b1*-dependent cell membrane contractility of MEFs. Therefore, we examined the distribution of the other proteins defining cleavage furrow formation including RhoA and its downstream effectors, like contractile ring components and actomyosin. We found that RhoA and Anillin were mislocalized in *Pafah1b1* mutant MEFs. For instance, RhoA was found in ectopically localized in large polar blebs in *Pafah1b1* mutant MEFs. The Myosin II-positive and F-actin focus zone were dispersed at the equatorial cortex or aberrantly located at the polar blebs in *Pafah1b1* mutant MEFs. By alternatively tracing MRLC1 and SEPT6, we confirmed that LIS1 defines cleavage plane positioning by dual regulation of actomyosin and contractile ring. Finally, RhoA hyper-activation in WT MEFs phenocopied the cytokinesis defects seen in *Pafah1b1* mutant MEFs, and inhibition of RhoA in *Pafah1b1* mutant MEFs decreased the cytokinesis defects observed in these MEFs. Thus, these results suggest that LIS1 exerts its function to restrict the cleavage furrow at the equatorial cortex to finely modulate RhoA-Anillin-actomyosin signaling.

Previous *Pafah1b1* mutant mouse studies demonstrated that LIS1 modulates GTPase-mediated F-actin dynamics in interphase cells and post-mitotic neurons. For example, *Pafah1b1* heterozygous (*Pafah1b1^ko/+^*) post-mitotic neurons displayed F-actin dysregulation at the leading processes and aberrant GTPase activities of RhoA-Rac1-Cdc42. Similarly, *Pafah1b1^ko/+^* MEFs exhibited abnormal hyper-activation of RhoA GTPase ([@bib34]). A recent *Pafah1b1* knockdown fibroblast study also unraveled F-actin dysfunction and focal adhesion disruption during traction-dependent migration ([@bib31]). Together, these previous findings indicate that LIS1 may regulate not only MTs but F-actin in migrating phases of multiple cell types. Based on the aberrant cytokinetic phenotypes seen in *Pafah1b1* mutant NPCs and MEFs, we now demonstrate that loss of LIS1 results in hyper-activation of RhoA signaling and mislocalization of F-actin and Myosin II that generates hyper-contractility forces ectopically at the polar cortex, which is an abnormal site of cleavage furrow ingression.

Multiple mouse studies have suggested that RhoA GTPase regulates the integrity of the apical NPC niche, through controlling F-actin at the adherens junction ([@bib7]; [@bib27]; [@bib32]). In accordance with this finding, a study of chick neural tube development indicated that RhoA activity modulation and overexpression of a DN-RhoA similarly altered mitotic spindle orientation of apical NPCs ([@bib55]). In the present study, we demonstrated that neocortical LIS1 is an important upstream mediator of signaling cascades of RhoA-actomyosin-contractile ring components during cytokinesis of apical NPCs. In mouse apical NPCs, Anillin-ring constriction from the basal to apical side determines the cleavage furrow ingression site in mouse apical NPCs ([@bib37]). During cytokinesis of neocortical NPCs, Citron kinase and RhoA colocalize at the apical membrane of NPCs where the cleavage furrow and the midbody are positioned ([@bib10]; [@bib56]). In mice, mutations in Citron kinase alter mitotic spindles and RhoA-mediated neurogenic cytokinesis of apical NPCs. In humans, neocortical NPC phenotypes lead to primary microcephaly and microlissencephaly ([@bib1]; [@bib38]; [@bib59]; [@bib24]; [@bib16]). Furthermore, in addition to Citron kinase and RhoA, three members of Kinesin family, Kif20a, Kif20b, and Kif4 regulate neocortical NPC cytokinesis and mutations of these genes result in reduced cortical size with microcephaly ([@bib30]; [@bib43]; [@bib19]). Together, these previous studies suggest that dynamic movements of RhoA and cleavage furrow-associated proteins to the midbody is the key cellular process regulating NPC cytokinesis by precisely segregating cell determinants along the cell cleavage axis.

In the developing neocortex, apical NPCs self-renew via symmetric divisions, and produce the major populations of post-mitotic neurons via asymmetric divisions. The orientiation of the cleavage plane is thought to be a major regulator of symmetric versus asymmetric cleavage. Our present study suggests that the LIS1-RhoA-actomyosin pathway sets the apical NPC cleavage plane by enrichment of cytokinetic furrow proteins to the ventricular surface, contributing to the later mitotic events when cell fate determinants separate into the daughter cells. Immunohistochemical analyses of the mouse neocortex uncovered that *Pafah1b1* mutant NPCs displayed mislocalization of RhoA and Anillin skewed to only one daughter cell, indicating unequal inheritance and this may impact the segregation of cell fate determinants by inducing an imbalance of symmetric versus asymmetric divisions. Consistent with this data, we previously reported that *Pafah1b1*-deficient E14.5 neocortex had an increase in TUJ1-positive neurons and cleaved caspase-3-positive apoptotic cells ([@bib17]). This suggests that neocortical daughter cell fates and survival/death are sensitive to LIS1 expression levels in neocortical NPCs. We also demonstrated that *Pafah1b1*-deficient E15.5 neocortex displayed partial diffuseness and thinning of cortical plate with weak formation of the subplate. In the cortex of postnatal day 5 NPC-specific *Pafah1b1* CKO mice (*GFAP-Cre; Pafah1b1^hc/hc^*) also had reduced numbers of upper-layer neurons marked by FOXP1 (Layer III/VI) and CUX1 (Layer II/III) ([@bib69]), indicating that *Pafah1b1* deficiency in NPCs leads to impairments in neuronal subtype specification and total neurogenesis accompanied with cortical patterning defects.

In the present study, we observed mitotic phenotypes from apical NPCs, the vRGs, in the E14 neocortex. *Pafah1b1* deficiency at earlier time points (E9.5\~E11.5) resulted in neural epithelial stem cell death via apoptotis, due to disruption of symmetric mitotic division with vertical cleavage plane, so these earlier stem cells could not be studied. At mid-gestation, we were able to utilize conventional hypomorphic mutants and NPC-specific CKO mutants and circumbented mitotic arrest and death mechanisms. E14 vRGs had a sufficient amount of LIS1 to avoid severe mitotic catastrophe and still displayed robust cytokinetic defects with distorted cleavage plane and mitotic spindles.

Our novel findings of LIS1 functions in cytokinesis may explain the mechanism of the recent studies with induced pluripotent stem cells (iPSCs) of Miller Dieker syndrome, a severe form of lissencephaly with haploinsufficiency of *PAFAH1B1* as well as about 20 other genes. We demonstrated a prolongation of mitosis of oRG progenitors but not ventricular zone radial glial (vRG) progenitors ([@bib4]). The specificity of mitotic effects in the oRGs and lack of its effects in the vRGs may be the result of different dose dependencies of LIS1 in mouse vs. human, such that LIS1 deficiency results in more prolonged mitotic time specifically in oRGs rather than vRGs. Compared with vRGs, oRG populations lack their endfeet attachment to the apical VZ surface. Intriguingly, human oRGs exhibit rapid mitotic somal translocation toward the cortical plate right before cytokinesis ([@bib23]). These abrupt movements of human oRGs suggest dynamic cytoskeletal rearrangements during mitotic phases of oRGs. In our current mouse studies, we could not investigate oRG phenotypes due to the low number oRGs present in the neocortices of mice. By contrast, the neocortices of gyrencephalic mammals (from the ferret to primates) contain substantial number of oRGs that exhibit unique mitotic somal translocation, unrestricted mitotic spindle angles, multiple rounds NPC self-renewal and promote expansion of progenitors, neocortical folding and increased topology. Since oRGs highly express a specialized transcriptional factor, HOPX ([@bib51]) on top of the pan-RG markers PAX6 and SOX2, it would be crucial to investigate the orchestrated crosstalk between HOPX-dependent transcriptional/epigenetic network and actomyosin-mediated cytokinesis in oRGs. In the future, characterization of the localization of diverse protein markers enriched to the cleavage furrow in human or primate iPSC-derived NPCs and fetal neocortical NPCs, such as RhoA, Anillin, and Citron kinase of NPCs, will need to be analyzed to better understand the oRG-specific sensitivity to LIS1 dosage especially in human. It would also be interesting to determine whether other lissencephaly or brain malformation-associated genes modulate RhoA-Anillin-actomyosin-pathways, and to test whether these genes, like LIS1, also possess dual roles in actomyosin and MT regulation important for apical NPCs by controlling key cellular processes not only mitosis but cytokinesis, a critical final step of cell determinant segregation.

Materials and methods {#s4}
=====================

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Reagent type\                              Designation                    Source or\                                                                                  Identifiers                                                        Additional\                             
  (species) or\                                                             reference                                                                                                                                                      information                             
  resource                                                                                                                                                                                                                                                                         
  ------------------------------------------ ------------------------------ ------------------------------------------------------------------------------------------- ------------------------------------------------------------------ --------------------------------------- --
  Strain, strain background\                 *CAGG-CreERT2*                 [@bib26]                                                                                                                                                                                               
  *Mus musculus*                                                                                                                                                                                                                                                                   

  Strain, strain background *Mus musculus*   *Pafah1b1^hc/+^*\              [@bib67];\                                                                                                                                                                                             
                                             *Pafah1b1^hc/hc^*\             [@bib44]                                                                                                                                                                                               
                                             *Pafah1b1^hc/ko^*                                                                                                                                                                                                                     

  Strain, strain background\                 *GFAP-Cre*                     [@bib72]                                                                                                                                                                                               
  *Mus musculus*                                                                                                                                                                                                                                                                   

  Strain, strain\                            *MADM-11^GT/TG^; Emx1^Cre+^*   [@bib28]                                                                                                                                                                                               
  Background\                                                                                                                                                                                                                                                                      
  *Mus musculus*                                                                                                                                                                                                                                                                   

  Cell line\                                 HEK293T\                       ATCC                                                                                        CRL-3216                                                           Negative for Mycoplasma contamination   
  (*Homo sapiens*)                           (kidney, embryonic)                                                                                                                                                                                                                   

  Antibody                                   Anti-Cleaved caspase3\         Cell Signaling                                                                              Cat\# 9661\                                                        ICC (1:500)                             
                                             (Rabbit polyclonal)                                                                                                        (RRID:[AB_2341188](https://scicrunch.org/resolver/AB_2341188))                                             

  Antibody                                   Anti-α-Tubulin\                AbD Serotec                                                                                 Cat\# MCA77G\                                                      ICC\                                    
                                             (Rat monoclonal)                                                                                                           (RRID:[AB_325003](https://scicrunch.org/resolver/AB_325003))       (1:1,000)                               

  Antibody                                   Anti-RhoA\                     Santa Cruz                                                                                  Cat\# sc-418\                                                      ICC, IHC\                               
                                             (Mouse monoclonal)                                                                                                         (RRID:[AB_628218](https://scicrunch.org/resolver/AB_628218))       (1:500)                                 

  Antibody                                   Anti-Anillin\                  Santa Cruz                                                                                  Cat\# sc-67327\                                                    ICC, IHC\                               
                                             (Rabbit polyclonal)                                                                                                        (RRID:[AB_2058302](https://scicrunch.org/resolver/AB_2058302))     (1:250)                                 

  Antibody                                   Anti-LIS1\                     Abcam                                                                                       Cat\# ab2607\                                                      ICC\                                    
                                             (Rabbit polycloncal)                                                                                                       (RRID:[AB_2299251](https://scicrunch.org/resolver/AB_2299251))     (1:250)                                 

  Antibody                                   Anti-P150^glued^\              BD bioscience                                                                               Cat\# 610473\                                                      ICC\                                    
                                             (Mouse monoclonal)                                                                                                         (RRID:[AB_397845](https://scicrunch.org/resolver/AB_397845))       (1:200)                                 

  Antibody                                   Anti-DIC 74.1\                 Millipore                                                                                   Cat\# MAB1618\                                                     ICC\                                    
                                             (Mouse monoclonal)                                                                                                         (RRID:[AB_2246059](https://scicrunch.org/resolver/AB_2246059))     (1:100)                                 

  Antibody                                   Anti-NMHCIIA\                  Covance                                                                                     Cat\# PRB-440P\                                                    ICC (1:1,000)                           
                                             (Rabbit polyclonal)                                                                                                        (RRID:[AB_291638](https://scicrunch.org/resolver/AB_291638))                                               

  Antibody                                   Anti-GFP\                      Invitrogen                                                                                  Cat\# A-11120 (Clone 3E6)\                                         ICC\                                    
                                             (Mouse monoclonal)                                                                                                         (RRID:[AB_221568](https://scicrunch.org/resolver/AB_221568))       (1:500)                                 

  Antibody                                   Anti-MPM2\                     Millipore                                                                                   Cat\# 05--368\                                                     IHC\                                    
                                             (Mouse monoclonal)                                                                                                         (RRID:[AB_309698](https://scicrunch.org/resolver/AB_309698))       (1:200)                                 

  Antibody                                   Anti-N-Cadherin\               BD bioscience                                                                               Cat\# 610920\                                                      IHC\                                    
                                             (Mouse monoclonal)                                                                                                         (RRID:[AB_2077527](https://scicrunch.org/resolver/AB_2077527))     (1:100)                                 

  Antibody                                   Anti-aPKC (PKCζ)\              Santa Cruz                                                                                  Cat\# sc-216\                                                      IHC\                                    
                                             (Rabbit polyclonal)                                                                                                        (Clone C-20)\                                                      (1:100)                                 
                                                                                                                                                                        (RRID:[AB_2300359](https://scicrunch.org/resolver/AB_2300359))                                             

  Antibody                                   Anti-GFP\                      Aves                                                                                        Cat\# GFP1010\                                                     IHC\                                    
                                             (Chicken polyclonal)                                                                                                       (RRID:[AB_2307313](https://scicrunch.org/resolver/AB_2307313))     (1:500)                                 

  Antibody                                   Anti-c-Myc\                    Novus biologicals                                                                           Cat\# NB-600--335\                                                 IHC\                                    
                                             (Goat polyclonal)\                                                                                                         (RRID:[AB_10002720](https://scicrunch.org/resolver/AB_10002720))   (1:150)                                 
                                             (detecting tdTomato-c-Myc)                                                                                                                                                                                                            

  Recombinant DNA reagent                    pCX-mCherry-αTub               Previously generated.\                                                                                                                                                                                 
                                                                            [@bib44]                                                                                                                                                                                               

  Recombinant DNA reagent                    pCX-MRLC1-GFP                  Tom Egelhoff (Cleveland Clinic, Cleveland, OH, USA)                                                                                                            Addgene plasmid\                        
                                                                                                                                                                                                                                           \#35680                                 

  Recombinant DNA reagent                    pCX-SEPT6-GFP                  Matthew Krummel (UCSF, San Francisco, CA, USA)                                                                                                                 Described in\                           
                                                                                                                                                                                                                                           [@bib20]                                

  Recombinant DNA reagent                    pCX-H2B-tdTomato               Geoffrey Wahl (Salk Institute, San Diego, CA, USA) Roger Tsien (UCSD, San Diego, CA, USA)                                                                      Addgene plasmid\                        
                                                                                                                                                                                                                                           \#17735                                 

  Recombinant DNA reagent                    pCX-DN-RhoA, pCX-CA-RhoA       Kozo Kaibuchi (Nagoya University, Nagoya, Japan)                                                                                                                                                       
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Animals {#s4-1}
-------

The mouse lines used in the present study were previously described; *CAGG-CreERT2* ([@bib26]), *Pafah1b1^hc/+^,Pafah1b1^hc/hc^* and *Pafah1b1^hc/ko^* ([@bib67]; [@bib44]), *GFAP-Cre* ([@bib72]), *MADM-11^GT/TG,Lis1^;Emx1^Cre/+^* ([@bib28]). All animal care and experimental procedures (Protocol ID: AN085137-02A) were approved by the University of California, San Francisco Institutional Animal Care and Use Committee (IACUC) in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals.

Cell culture and immunocytochemistry {#s4-2}
------------------------------------

Primary MEFs cell culture was performed as previously described [@bib44]. Cre recombinase in *CAGG-CreERT2*-MEFs was induced by administration of 4-hydroxy tamoxifen (TM) (Sigma, 100 nM) for 12 hr. DMSO and blebbistatin (Calbiochem, 100 μM) were used to treat MEFs for 30 min. To identify RhoA in the cortex and cleavage furrow, MEFs were fixed with freshly made 10% trichloroacetic acid (TCA) for 10 min ([@bib68]). Immunocytochemistry staining of cortical P150^glued^, was performed in 100% methanol-fixed samples as previously described [@bib44]. The antibodies used in this study were listed in Key Resources Table.

Retrovirus infection, epifluorescence and spinning-disk confocal live-cell imaging {#s4-3}
----------------------------------------------------------------------------------

Time-lapse live-cell imaging of MEFs infected with retroviruses encoding H2B-GFP, mCherry-α-Tubulin was described previously [@bib44]. To induce Cre-mediated *Pafah1b1* CKO allele deletion, the MEFs derived from *CAGG-CreERT2; Pafah1b1^+/+^* and *CAGG-CreERT2; Pafah1b1^hc/hc^* animals were treated with 4-hydroxy-tamoxifen (TM) (Sigma, 100 nM) for 12 hr or 24 hr. To visualize Myosin II movements during cytokinesis, primary MEFs were co-infected with a mixture of MRLC1-GFP and H2B-tdTomato retroviruses with 4 μg/mL polybrene. Lasers with 488 nm and 561 nm emission were used for GFP and tdTomato imaging. SEPT6-GFP was also traced by a Nikon Ti spinning-disk confocal microscope with a 488 nm emission laser. The sequential 2 μm interval 5 \~ 7 Z-stack images were captured every 30 s. The best Z confocal plane images showing the cleavage furrow were made as time-lapse movies. The plasmid sources of retrovirus construction were described in Key Resources Table.

Immunohistochemistry {#s4-4}
--------------------

Mouse fetal brains were isolated from E14.5 embryos described in [@bib67] followed by fixation with 4% paraformaldehyde (PFA) or 10% TCA (RhoA staining). On the next day, the brains were transferred to 30% sucrose and embedded in O.C.T. compound to make cryomolds. 18 μm- thick cryostat sections of neocortex were used for immunohistochemistry. In *MADM-11* animals, we identified *Lis1* genotype based on GFP or tdT immunoreactivity. Cleavage furrow markers such as Anillin and RhoA were immunostained in the far-red Alexa Fluor 647 channel to separate the fluorescence signal from GFP and tdT. Anillin- or RhoA-immunoreactive signals were pseudo-colored in green for representation purpose. The antibodies used in this study were listed in Key Resources Table.

Sample size, Replicates, and Statistical analysis {#s4-5}
-------------------------------------------------

Time-lapse live-cell imaging of primary MEFs was performed and data analyses were conducted from at least three independent experimental sets. Sample-size from live-cell imaging for data analysis was calculated based on empirical sample-size previously tested from mitotic analysis of *Pafah1b1* mutant MEF study ([@bib44]). In all MEF live-cell imaging experiments, the exact cell number recorded for monitoring whole duration of mitotic cell division (from prometaphase to telophase/cytokinesis) were written in Source data files. From the fixed samples for immunohistochemistry using the embryonic brains, the exact number of cells taken for confocal images of apical NPCs located at the ventricular zone was recorded in Source data files. In immunocytochemistry analysis of MEFs, the exact sample number of cells for taking confocal images was recorded in Source data files. No data points were excluded for statistical analysis and all raw data points were included. Two-tailed Student's *t*-test was used to compare mitotic cellular phenotypes and to evaluate statistical significance and differences between controls and *Pafah1b1* mutant groups. \*p\<0.05, \*\*p\<0.01, \*\*\*p\<0.001, ns: not significant. Bars in the graphs with error bars represented: mean ± S.E.M.

Funding Information
===================

This paper was supported by the following grants:

-   http://dx.doi.org/10.13039/100000065National Institute of Neurological Disorders and Stroke NIH-R01-NS041030 to Anthony Wynshaw-Boris.

-   http://dx.doi.org/10.13039/100009633Eunice Kennedy Shriver National Institute of Child Health and Human Development NIH-R01-HD047380 to Anthony Wynshaw-Boris.

-   http://dx.doi.org/10.13039/100008069University of California, San Francisco Graduate Student Research Award to Hyang Mi Moon.

We would like to thank Dr. Arshad Desai and Dr. Karen Oegema in UCSD for providing initial key insights into the novel phenotypes seen in *Lis1* mutant MEFs, Dr. Torsten Wittmann, Hayley Pemble, Kurt Thorn at Nikon imaging center in UCSF for access to microscopes for time-lapse live-cell imaging, Dr. Matthew Krummel in UCSF for Septin6-GFP plasmid, Dr. Kozo Kaibuchi in Nagoya University for RhoA plasmids and insightful advice, and Dr. Giles Plant in Stanford University for access to Nikon imaging analysis.

Additional information {#s5}
======================

No competing interests declared.

Conceptualization, Resources, Data curation, Formal analysis, Supervision, Validation, Investigation, Visualization, Methodology, Project administration.

Resources, Visualization, Methodology.

Resources, Methodology.

Conceptualization, Data curation, Supervision, Funding acquisition, Validation, Investigation, Project administration.

Animal experimentation: All animal care and experimental procedures were approved by the University of California, San Francisco Institutional Animal Care and Use Committee (IACUC) in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals. Protocol ID: AN085137-02A.

Additional files {#s6}
================

Data availability {#s7}
=================

All data analyzed during this study and its analysis has been described in the manuscript.
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In the interests of transparency, eLife publishes the most substantive revision requests and the accompanying author responses.

**Acceptance summary:**

The authors carry out detailed experiments aimed at uncovering the role of LIS1-Dynein-Microtubules in cytokinetic plane specification. They investigate the functions in two cell types, Neural Progenitor Cells and Mouse Embryonic Fibroblasts. Through extensive genetic and imaging studies the authors reveal links between LIS11 and the RhoA-Anillin-Actin-Myosin II and how this network positions the cell division site.

**Decision letter after peer review:**

Thank you for submitting your article \"LIS1 determines cleavage plane positioning by regulating actomyosin-mediated cell membrane contractility\" for consideration by *eLife*. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Anna Akhmanova as the Senior Editor. The following individual involved in review of your submission has agreed to reveal their identity: Hongyan Wang (Reviewer \#1).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

All the three reviewers were enthusiastic about the new role for LIS1 that you and colleagues describe in actomyosin and membrane contractility in neocortical neural progenitor cells. They have raised a number of points, which have all been compiled below and I request you to consider them carefully. One point brought up more than once by the reviewers is the modest quantitative information in your paper. This needs to be improved. Please pay particular attention to the points raised below, with respect to the physical interactions, cell type specificity, as well as relevance of MEF work. A number of new experiments may be required to address these points, in addition to substantial rewriting as suggested in point 6.

Essential revisions:

1\) Does LIS1 physically associates with the RhoA and Anillin to regulate cytokinesis? Or the regulation between LIS1 and RhoA and Anillin is indirect. Please explain these possibilities.

2\) Quantitative data need to be improved. Please indicate the exact sample size of experiment whenever possible. Very often the sample sizes in the manuscript are shown as \"more than twenty cells\", \"more than twenty apical NPCs\", \"at least thirty cells\". The authors should indicate the n number in each experiment and figure and present the data as \"mean ± S.E.M\" as much as possible. The population of abnormal division of NPCs were not quantified in Figure 1 and Figure 2.

3\) It would be helpful to connect the disordered division, and shifts in asymmetric and symmetric division that the authors report to the ultimate functional impact in the neuronal cell population. Further could the authors clarify if this dependence is somehow specific to this subtype of neuronal precursors?

4\) How much of the data generated in the MEFs is relevant for the NPCs of the neocortex? Is it possible to isolate neuronal precursors from the Lis1 null mice, or differentiate neurons towards these lineage to validate that some of the findings in MEFs hold true for NPCs? For example, is it possible to check whether the separation defects so effectively demonstrated in MEFs actually also occur in NPCs?

5\) The paper risks becoming somewhat descriptive at times. Better integration of the findings especially those in the MEFs, and connecting them to how Lis1 may impact NPC generation and functionality could help resolve this.

6\) While the results are well documented, the text needs considerable improvement. The authors did raise interesting questions in the Introduction, for example: why do LIS1 mutants specifically display a decrease in neuroepithelial stem cells in the neocortex compared with a less catastrophic phenotype seen in radial glial (RG) progenitors; does LIS1 have differential roles in mitotic division time between ventricular and subventricular radial glial progenitors? However, there is little answer to these questions in the paper with the current experimental design and methods. The work was partly carried out on mouse progenitor cells without differentiation of epithelial stem cell and radial glia cells and partly on MEFs which have significant limitations relevant to answer the main the questions. The difference between neuronal migration and cortical development in lisencephalic rodent (mouse) and gyrensephlaic primate (human) is not sufficiently emphasized. The Introduction and Discussion are not scholarly written and historically informed to be useful to a multidisciplinary audience of a journal like *eLife*. For example, while citing themselves profusely (10 times!?), the seminal papers by Reiner Orly on LIS1 gene are conspicuously missing.

10.7554/eLife.51512.sa2

Author response

> All the three reviewers were enthusiastic about the new role for LIS1 that you and colleagues describe in actomyosin and membrane contractility in neocortical neural progenitor cells. They have raised a number of points, which have all been compiled below and I request you to consider them carefully. One point brought up more than once by the reviewers is the modest quantitative information in your paper. This needs to be improved. Please pay particular attention to the points raised below, with respect to the physical interactions, cell type specificity, as well as relevance of MEF work. A number of new experiments may be required to address these points, in addition to substantial rewriting as suggested in point 6.

Please see our responses to Essential revisions \#1, \#3 and \#5.

> Essential revisions:
>
> 1\) Does LIS1 physically associates with the RhoA and Anillin to regulate cytokinesis? Or the regulation between LIS1 and RhoA and Anillin is indirect. Please explain these possibilities.

Physical interactions.

We thank the reviewers raising these interesting points regarding physical interaction of LIS1 and cytokinesis regulators (RhoA and Anillin). Although we performed immunocytochemistry experiments on MEFs with the individual antibodies during later stage of mitosis and cytokinesis, it was not possible to perform the co-localization experiments between LIS1 and other cytokinesis regulators. Since LIS1 and Anillin antibodies are derived from the same species, Rabbit, co-localization between these two proteins (LIS1-Anillin) was not able to be examined on MEFs simultaneously. On the other hand, membrane-bound RhoA required specific fixation method (TCA solution). However, endogenous intracellular distribution of LIS1 was different in 4% PFA vs. 10% TCA-fixation. Here, in the response to reviewers, we attached immunocytochemistry images of antibodies detecting LIS1 and Anillin using MEFs. We found no evidence of substantial overlap of intercellular compartments of LIS1-Anillin. In mitotic division of wild-type (WT) MEFs, LIS1 is localized only to the centrosomes in metaphase-to-anaphase and the central MTs during cytokinesis displaying mostly cytosolic distribution (Figure 7A), while Anillin is initially seen on the lateral cortex and later specifically accumulate in the cytokinetic abcission ring between two central MT bundles, near the equatorial cortex (Figure 7B). As we have shown in WT MEFs (Figure 6A), RhoA and Anillin are co-localized at the equatorial cortex and the midbody during cytokinesis. However, these two proteins display distinct membrane-associated enrichment compared with cytosolic LIS1. Our experimental evidence supports that LIS1 may only 'indirectly' regulate RhoA and Anillin through F-actin cytoskeleton regulation. A previous study (Kholmanskiki et al., 2003) demonstrated that *Pafah1b1*-deficient heterozygous MEFs have less amounts of the active form of GTP-bound RhoA without altering expression levels of total RhoA protein. This result suggests that RhoA may be in the downstream signaling pathway modulated by LIS1 dose. Our rescue experiments with CA-RhoA also suggest that GTPase activity and biological functions of RhoA may be indirectly modulated by LIS1 expression levels in the mitotic cells. These arguments certainly do not rule out a low level of direct interaction between LIS1 and Anilin/RhoA, which would require GST-pull down assays or two-hybrid phage array with recombinant proteins. We believe these are beyond the scope of the current manuscript and can be performed in the future.

We have inserted text in the last paragraph of the subsection "Mislocalization of RhoA and contractile ring components in mitosis of *Pafah1b1* mutant MEFs\".

> 2\) Quantitative data need to be improved. Please indicate the exact sample size of experiment whenever possible. Very often the sample sizes in the manuscript are shown as \"more than twenty cells\", \"more than twenty apical NPCs\", \"at least thirty cells\". The authors should indicate the n number in each experiment and figure and present the data as \"mean ± S.E.M\" as much as possible. The population of abnormal division of NPCs were not quantified in Figure 1 and Figure 2.

We thank all reviewers for pointing out the importance of providing accurate quantification and sample number/size. We made a new source data files to include all this data (n=brain samples or MEF cell number, N=independently replicated experiments). All data associated with the each figure were represented with detailed description. The subgrouping category identifying different groups based on the cellular phenotypes was also explained (Figures 1, 2, 3, 6, 8, 11). The graphs in Figure 4 and Figure 5 have mean ± S.E.M. values (also integrated in the texts in the Results section) and the exact *p*-values from Student's two-tailed *t*-test were provided in source data files. We also quantified the phenotypes of RG cells included in Figure 1 and Figure 2 (Figure 1---source data 1, Figure 2---source data 1).

As noted above, we have included new source data files. Text in Materials and methods, subsection "Sample size, Replicates, and Statistical analysis", was updated.

> 3\) It would be helpful to connect the disordered division, and shifts in asymmetric and symmetric division that the authors report to the ultimate functional impact in the neuronal cell population. Further could the authors clarify if this dependence is somehow specific to this subtype of neuronal precursors?

We thank the reviewers for raising these important questions regarding the functional outcomes affecting neuronal subtypes born from *Pafah1b1*-deficiency in NPCs and the long-term effects of daughter cell fates. At around E14.5, asymmetric divisions generate one NPC and one neuron and, in contrast, symmetric divisions generate two NPCs. Since *Pafah1b1*-deficiency in NPCs induces an increase in asymmetric divisions with oblique spindle angles, it is expected that number of neuronal cells may be ultimately increased. In accordance with this, *Pafah1b1*-deficient neocortex had an increase in TUJ1-positive cells abnormally located in the VZ, indicating delayed migration of post-mitotic neurons (Gambello et al., 2003). Previously published data from our laboratory of cleaved caspase-3 staining and TUNEL assay from *Pafah1b1*-deficient neocortex (Yingling et al., 2008) indicate that the apoptotic events were increased at E14.5. This suggests that final cell fate determination affecting a balance between cell death and survival were disrupted by *Pafah1b1*-deficiency in NPCs.

In our current study, we mainly analyzed RG phenotypes from various *Pafah1b1* mutants at E14.5 mid-gestational time point. We agreed with the reviewers that it is important to assess the long-term effects from LIS1 dose changes in RGs by the follow-up of later-gestational time point. In our previous study, we demonstrated that there were LIS1 dose-dependent changes in cortical patterning in the neocortex. Although *Pafah1b1*-deficient neocortex (*Pafah1b1 hc/ko*) at E15.5 had a distinct cortical plate, due to weak formation of the subplate boundary, the cortical plate (CP) was partly diffused to the intermediate zone. At a later time point P0 (post-natal day 0), the diffuseness and thinning of E15.5-born BrdU labeled cells were evident in *Pafah1b1* mutant neocortex with reduced cortical thickness (Gambello et al., 2003). Consistent with conventional *Pafah1b1*-deficient mutant (*Pafah1b1 hc/ko),* NPC-specific *Pafah1b1* CKO mice (*GFAP-Cre; Pafah1b1 hc/hc*) also exhibited similar cortical patterning defects at P5. Immunohistochemistry analyses with upper layer-specific FOXP1 (Layer III/VI) and CUX1 (Layer II/III) projection neuronal makers suggest that *Pafah1b1* CKO neocortex has significantly reduced immunoreactive cells in both layers compared with control (*GFAP-Cre; Pafah1b1 hc/+)* (Youn et al., 2009). Altogether, increased TUJ1+ cells and decreased FOXP1+ and CUX1+ cells in *Pafah1b1*-deficient neocortex indicate that RG-derived neuronal populations have impairments in neuronal subtype specification and total neurogenesis inputs. Reduced LIS1 dose in apical RGs has long-range adverse impact on CP patterning and layering by dysregulating neuronal production and subtype alterations of the daughter cells.

To address these points in the manuscript, we have added text to the seventh paragraph of the Discussion.

> 4\) How much of the data generated in the MEFs is relevant for the NPCs of the neocortex? Is it possible to isolate neuronal precursors from the Lis1 null mice, or differentiate neurons towards these lineage to validate that some of the findings in MEFs hold true for NPCs? For example, is it possible to check whether the separation defects so effectively demonstrated in MEFs actually also occur in NPCs?

Effects of LIS1 on long-term functional outcomes and neuronal subtype/lineage specification in neocortical development were discussed in the response to the point 3 above. Additional text was added to the Discussion to address these questions. Points discussed in this point 4 and point 5 were addressed together below.

> 5\) The paper risks becoming somewhat descriptive at times. Better integration of the findings especially those in the MEFs, and connecting them to how Lis1 may impact NPC generation and functionality could help resolve this.

\[Points 4 and 5\]: MEFs and NPCs.

We agree with the reviewers about importance of additional explanations of descriptions covering key limitations and advantages of MEFs compared with the usage of NPCs. We initially performed in vitro NPC primary culture from WT (*Pafah1b1 +/+)* and *Pahah1b1 hc/ko* mice. Conventional NPC protocols of NPC utilizing basal N2 medium with incubation on coated plates was used (Youn et al., 2013 -- previously described in our group's publication). Although WT NPCs normally grew in this culture condition, *Pafah1b1 hc/ko* NPCs did not, probably due to severe mitotic arrest at prometaphase and metaphase. It was not possible to maintain and propagate *Pafah1b1 hc/ko*NPCs in vitro. Therefore, we do not know whether *Pafah1b1*-deficient NPCs in vitro have exactly same phenotypes or even worse cytokinetic progression than MEFs in vitro. Our previously published study (Yingling et al., 2008) suggests that *Pafah1b1*-deficient NPCs have less proliferation/self-renewal capability with reduced phospho-Histone H3 mitotic index. It was assumed that asymmetric divisions generating neuronal cell types may increase in *Pafah1b1*-deficient NPCs due to alterations of vertical mitotic spindle angles.

Although *Pafah1b1-*deficient NPCs did not grow well in culture, we were able to successfully propagate *Pafah1b1 hc/ko* MEFs (derived from E14.5) and perform several in-depth cellular analyses by immunocytochemistry and live-cell imaging that were not technically possible in *Pafah1b1*-deficient NPCs. This suggests that *Pafah1b1*-deficiency in different cell types dissected from different tissue (CNS vs. skin) leads to distinct abilities to grow in vitro. This is not surprising, since humans with heterozygous loss of LIS1 display specific brain phenotypes without noticeable defects in other tissues, Mouse neocortical NPCs express specific nuclear transcription factors (such as PAX6, SOX2) to maintain its proliferative capacity and potency to promote neurogenesis. MEFs are subsets of the fibroblasts eventually undergo cellular senescence. NPCs uniquely undergo complex basal-to-apical abcission-mediated cytokinetic process in vivo. NPCs also generate one daughter cell with a different fate, a neuron with different lineage depending on the birth date and subtypes of NPCs in regionally specified neocortical domain. By contrast, MEFs only generate two MEFs with symmetric divisions.

However, there are many similarities which we believe allow us to use MEFs to study these phenotypes. Although MEFs and NPCs are isolated from the different source of tissue origins, LIS1 mutant cells expressed the same amount of LIS1 protein (35%) compared with WT (100%). LIS1-dose sensitivity in NPCs may lead to more severe mitotic phenotypes. Despite this disparity, both MEFs and NPCs have shared cellular and cytoarchitectural features during cytokinesis. We confirmed that NPCs retain apical RhoA and Anillin localization when they undergo cytokinesis at the ventricular surface where F-actin polarization occurred in vivo. RhoA and Anillin play crucial roles in determining cytokinetic furrow localization by cross-interacting with F-actin and Myosin II at the equatorial cell membrane and midbody. Thus, it appears that RhoA and Anillin-mediated cytokinetic furrow formation is controlled in a similar manner in both MEFs in vitro and apical NPCs in vivo (vRGs).

It is noteworthy that multiple in vitro studies have highlighted that genetic mutant MEFs are versatile and reliable cell types to investigate cellular mechanisms underlying cytokinetic defects, including cytokinesis defects in the brain (Janisch et al., 2013; Rosario et al., 2010; Cook et al., 2011; Serres et al., 2012). In genetically targeted MEFs with reduced protein dose (e.g. Kif20b, Plk4, Ect2, and P27), cytokinesis-associated phenotypes are found, including multi-nucleation and centrosome amplification. Dysregulated or mislocalized RhoA are commonly found as upstream mechanisms. Ectopic actomyosin localization away from the midbody leads to abcission failure and formation of aberrant inter-cellular bridge. Although transformed cell lines are widely used cell types to study cytokinesis-related mechanisms, primary cell types like MEFs derived from the well-defined genotypes are important tools to study targeting developmentally critical early embryonic time point. In particular, *Kif20b -/-* KO mutant MEFs exhibited no detectable AuroraB-positive midbody indicating failure in abcission during cytokinesis. Interestingly, *Kif20b -/-* RGs in the neocortex also had reduced numbers of AuroraB-positive midbodies at the apical surface of VZ (Janisch et al., 2013). Therefore, unlike RGs in the neocortex in vivo, the feasibility and durability of long-term live cell imaging of primary MEFs enabled us to measure variables and help reach better statistical power. Our work tracing the fluorescently labeled intracellular and membrane markers and immunocytochemistry with cytokinetic markers in *Pafah1b1* mutant MEFs are advantageous to elucidate the exact signaling pathways to regulate LIS1-dependent cytokinesis.

To address these points in the manuscript, we have added text to the second paragraph of the Discussion.

> 6\) While the results are well documented, the text needs considerable improvement. The authors did raise interesting questions in the Introduction, for example: why do LIS1 mutants specifically display a decrease in neuroepithelial stem cells in the neocortex compared with a less catastrophic phenotype seen in radial glial (RG) progenitors?

A\) We previously demonstrated that *Pafah1b1* deficiency in neural epithelial stem cells (NESCs) (E9.5\~11.5) display more severe mitotic defects than radial glial progenitor cells (RGPCs) (E12.5\~E14.5) during mouse neocortical development(Yingling et al., 2008). LIS1 is essential for precise control of mitotic spindle orientation in both NESCs and RGPCs. Controlled gene deletion of *Pafha1b1* in vivo in neuroepithelial stem cells, where cleavage is uniformly vertical and symmetrical, provokes rapid apoptosis of those cells, while radial glial progenitors are less affected because their divisions are symmetric and asymmetric.In the present study, we designed our experiments to dissect the mouse neocortices from E14.5 time-point. We selected these time-points because we narrowed the developing critical window of active and rapid neurogenesis in order to examine the effects of *Pafah1b1*-deficiency on NPC daughter cell's fate and cytokinetic separation. Therefore, almost all apical NPCs observed in the current study are expected to be RGPCs. We aimed to get mild but somewhat measurable defects in cytokinesis of RGPCs which overcome significantly increased cell death events and severe mitotic arrest seen NESCs.

To address these points in the manuscript, we have added text to the eighth paragraph of the Discussion.

> Does LIS1 have differential roles in mitotic division time between ventricular and subventricular radial glial progenitors? However, there is little answer to these questions in the paper with the current experimental design and methods. The work was partly carried out on mouse progenitor cells without differentiation of epithelial stem cell and radial glia cells.

B\) In human organoid models, the time between rounding of cells and their separation is similar between control vRGs and oRGs. However, in MDS organoids, there was a profound delay in oRG division and vRG division (Bershteyn et al., 2017), a point we discussed in the text. In the mouse neocortex, there are very few oRGs since this progenitor type is greatly expanded in primates. Mouse RGPCs are nearly all ventricular RGs (vRGs) associated physically with apical membrane of VZ surface, not outer RGs (oRGs) located at the subventicular zone (SVZ) area.

To address these points in the manuscript, we have added text to the last paragraph of the Discussion.

In response to these questions, additional information discussing the differences between oRG and vRG and human vs. mouse neocortical development were added in the first paragraph of the subsection "Mislocalization of RhoA and Anillin in *Pafah1b1* mutant neocortical neural progenitor cells (NPCs)" (a similar issue was covered in (D) section).

> ...and partly on MEFs which have significant limitations relevant to answer the main the questions. The difference between neuronal migration and cortical development in...

C\) We thank the reviewers for mentioning this crucial point highlighting the difference and limitation of simply applying the findings of MEF live-cell imaging analyses to NPCs in the developing neocortex. These concerns were addressed in the revised manuscript, as we discussed in Points (D) and (F).

To address these points in the manuscript, we have added text to the second paragraph of the Discussion.

> Lisencephalic rodent (mouse) and gyrensephlaic primate (human) is not sufficiently emphasized. The Introduction and Discussion are not scholarly written and historically informed to be useful to a multidisciplinary audience of a journal like eLife.

D\) A new paragraph was integrated to respond to this point (Discussion, last paragraph).

> For example, while citing themselves profusely (10 times!?)

E\) Yingling et al., 2008 manuscript was reduced to '7' citations in the current text. This particular citation has most relevant previous findings related to LIS1 dose-dependent RGPC phenotypes and mitotic spindle regulation. Therefore, we still kept this reference in multiple locations of the middle of the revised manuscript where citation is still critical and necessary to make understood the readers.

To address these points in the manuscript, we have added text in the Introduction, Results and Discussion sections.

> The seminal papers by Reiner Orly on LIS1 gene are conspicuously missing.

F\) We are sorry to miss certain historically important citations in this text. We did not omit it intentionally from the initial manuscript. When we followed the guideline of the reference numbers in *eLife* submission, various citations were subtracted. The Reiner et al., 1993 citation was added in the first paragraph of the Introduction, and in theReferences section.

[^1]: Department of Neurosurgery, Institute for Stem Cell Biology and Regenerative Medicine, Stanford University, Stanford, United States.

[^2]: IST Austria (Institute of Science and Technology Austria), Klosterneuburg, Austria.
